In previous studies, sCD163 is suggested to be increased in a panel of neurological diseases, such as intracranial hemorrhage (18), Parkinson's disease (19), Alzheimer's disease (20), and multiple sclerosis (21). This evidence concerns the gene CD163 and multiple sclerosis.